Immunization, HepB3 in Caribbean Small States
Caribbean Small States: Immunization, HepB3 was 89.6% in 2024. ◆ Volatile
Immunization, HepB3 in Caribbean Small States, 1985–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
Caribbean Small States recorded 89.6% for immunization, hepb3 in 2024.
Compared with earlier readings it is up 0.7% on the previous year and down 2.0% over ten years.
Over the whole period, immunization, hepb3 in Caribbean Small States peaked at 93.7% in 2018 and was at its lowest, 0.0%, in 1985.
Caribbean Small States ranks 12th of 47 groups on this measure, in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in Caribbean Small States, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1985 | 0.0% | — |
| 1986 | 0.0% | — |
| 1987 | 0.0% | — |
| 1988 | 0.0% | — |
| 1989 | 0.0% | — |
| 1990 | 0.0% | — |
| 1991 | 0.0% | — |
| 1992 | 0.0% | — |
| 1993 | 0.0% | — |
| 1994 | 0.0% | — |
| 1995 | 0.0% | — |
| 1996 | 0.0% | — |
| 1997 | 0.0% | — |
| 1998 | 1.0% | — |
| 1999 | 1.1% | +2.1% |
| 2000 | 7.9% | +641.5% |
| 2001 | 37.9% | +379.3% |
| 2002 | 48.4% | +27.8% |
| 2003 | 70.2% | +45.1% |
| 2004 | 77.3% | +10.0% |
| 2005 | 91.4% | +18.3% |
| 2006 | 89.5% | -2.0% |
| 2007 | 91.7% | +2.4% |
| 2008 | 90.9% | -0.9% |
| 2009 | 93.5% | +2.9% |
| 2010 | 92.2% | -1.5% |
| 2011 | 90.9% | -1.3% |
| 2012 | 91.9% | +1.0% |
| 2013 | 92.1% | +0.3% |
| 2014 | 91.5% | -0.8% |
| 2015 | 90.4% | -1.2% |
| 2016 | 93.3% | +3.2% |
| 2017 | 88.0% | -5.7% |
| 2018 | 93.7% | +6.5% |
| 2019 | 92.4% | -1.4% |
| 2020 | 85.6% | -7.4% |
| 2021 | 88.5% | +3.4% |
| 2022 | 89.4% | +1.0% |
| 2023 | 88.9% | -0.5% |
| 2024 | 89.6% | +0.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.0% | 0.0% | 0.0% | 5 |
| 1990s | 0.2% | 0.0% | 1.1% | 10 |
| 2000s | 69.9% | 7.9% | 93.5% | 10 |
| 2010s | 91.6% | 88.0% | 93.7% | 10 |
| 2020s | 88.4% | 85.6% | 89.6% | 5 |
More health data for Caribbean Small States
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 1.35 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0324 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 1.43 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0356 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, per capita 0.037 units per person (2025)
- Population ages 40-44, female, annual growth rate 1.58 % change on previous year (2025)
Frequently asked questions
- What is immunization, hepb3 in Caribbean Small States?
- Immunization, hepb3 in Caribbean Small States was 89.6% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Caribbean Small States?
- The highest recorded value was 93.7% in 2018.
- What is the lowest immunization, hepb3 recorded in Caribbean Small States?
- The lowest recorded value was 0.0% in 1985.
- How does Caribbean Small States rank for immunization, hepb3?
- Caribbean Small States ranks 12th out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in Caribbean Small States?
- Over the last ten years it is down 2.0%. The long-run trend across the full record is volatile.
- Where does this Caribbean Small States data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.